	A pathological morphology parameter-based prognostic nomogram for high-risk prostate cancer patients treated with neoadjuvant therapy followed by radical prostatectomy: a retrospective study. World J Surg Oncol Liang H, Fan J, Xu K, Song H, Gan C, Wang G, Kang Q, Liu J, He D, Fan J, Wu K. PMID: 42343460 [PubMed - as supplied by publisher]
	Evaluating the Surrogacy of Pathological Complete Response at Radical Cystectomy in Neoadjuvant-based Muscle-invasive Bladder Cancer Trials. Eur Urol Oncol Scilipoti P, , Thibault C, Doma, Necchi A, Montorsi F, Briganti A, Moschini M, Masson-Lecomte A, Kamat AM, Xylinas E, Pradere B, Shariat S, Trinh QD, Birtle A, Grande E, Bellmunt J, Loriot Y, Rouprêt M, Seisen T. PMID: 42342498 [PubMed - as supplied by publisher]
	Oncological Outcomes of Non-Muscle Invasive Bladder Cancer in Patients Aged â‰¤45: A Retrospective Matched Cohort Study. J Urol St-Laurent MP, Din S, Moryousef J, Lajkosz K, Kwong JCC, Chan A, Kim J, Taborek A, Chadee A, Sadri I, Reznik G, Tin C, Fleshner NE, Kulkarni GS, Black PC, Kassouf W, Zlotta AR. PMID: 42341207 [PubMed - as supplied by publisher]
	Robot-Assisted versus Laparoscopic Radical Nephrectomy for High-Complexity Renal Tumors: A Multidisciplinary Systematic Review and Meta-Analysis. Clin Ter Elnemr M, Sharif MH, Mahmoud HM, Abdalgaleel MA, Elshazly S, Mhanna T, Rezk T, Allam KA, Albachaan M, Ghoneimy OM, Aboelgheit G, Mohammed SA, Alaghbar K, Kayed AAA, Oda MA. PMID: 42340793 [PubMed - indexed for MEDLINE]
	Optimal MRI sequence for predicting extraprostatic extension in prostate cancer: comparison of LCC and MaxRADD measurements. Abdom Radiol (NY) Ilanjian G, Matthey J, Porões F, Valerio M, Richemond A, Dagher J, Rakauskas A, Dromain C, Jreige M, Vietti-Violi N. PMID: 42340465 [PubMed - as supplied by publisher]
	Correction: Assessment of radiotherapy effect and toxicity using tissue-associated DNA methylation markers in cell-free DNA: a study on prostate cancer. Radiat Environ Biophys Bahtiyar N, Mermut O, Firtina S, Ozaydin A, Suleymanova A, Isikgil B, Onaran . PMID: 42340384 [PubMed - as supplied by publisher]
	A Practical Guide to PSMA PET Radiopharmaceuticals for Prostate Cancer Imaging, From the AJR Special Series on Molecular Imaging. AJR Am J Roentgenol Peacock JG, Franquet-Elia E, Harris AL, Weeks JG, Kuo PH. PMID: 42340235 [PubMed - as supplied by publisher]
	Magnetic resonance imaging radiomic phenotypes stratify response and define immune states in very high-risk, nonmuscle-invasive bladder cancer treated with tislelizumab plus nanoparticle albumin-bound paclitaxel. Cancer Huang S, Jia K, Liang S, Ma B, Chen H, Zhang Z, Kang N, Wu Z, Lin Y, Li P, Xue Z, Chen H, Zhao Y, Guo J, Li C, Chai W, Cui J, Xu G, Qie Y, Shen C, Hu H. PMID: 42339693 [PubMed - indexed for MEDLINE]
	Diagnostic Value of Spectral CT-Derived Extracellular Volume Fraction in the Early Detection of Sigmoid Colon Metastasis from Bladder Cancer: A Case Report. Surg Case Rep Peng M, Shen L, Song D, Wen L, Xiang Y, Song L. PMID: 42339343 [PubMed]
	Papillary Renal Neoplasm with Reversed Polarity in a 64-Year-Old Male: A Rare Case Report and Review of the Literature. Int Med Case Rep J Wang Y, Zhang M, Su G, Zhou Q. PMID: 42339132 [PubMed]
	Exploring the molecular link between arecoline exposure and prostate cancer-related alterations: integrative evidence from network toxicology, single-cell transcriptomics, molecular simulation, and experimental validation. Front Pharmacol Zhu X, Liu H, Zeng Z, Zou L, Zhou Y, Zhou T. PMID: 42338969 [PubMed]
	Multi-omics analysis of kidney renal cell carcinoma in silico with preliminary in vivo validation. Front Immunol Su T, Jiang F, Gao J, Li X, Cheng H, Wang Y. PMID: 42338588 [PubMed - indexed for MEDLINE]
	Dual-scan conformal cone-beam CT for targeted image-quality improvement using dynamic collimation. J Appl Clin Med Phys Liu Y, Yuan S, Feng X, Dai J. PMID: 42338073 [PubMed - indexed for MEDLINE]
	The feasibility of [(18)F]PSMA-1007 PET/CT for response assessment in prostate cancer following neoadjuvant androgen deprivation therapy compared with mpMRI. Cancer Imaging Cho S, Seo HJ, Han H, Lee S, Jeon TJ, Oh YT, Jung M, Yun M. PMID: 42337687 [PubMed - as supplied by publisher]
	Identification of alpha1-oleate as a potent regulator of adipokine-dependent metabolism, in bladder cancer tissue. Cancer Metab Haq F, Chinchankar S, Ambite I, Ahmadi S, Tran H, Nazari A, Brisuda A, Hacek J, Babjuk M, Svanborg C. PMID: 42337683 [PubMed]
	Multi-omics integration and clinical validation identify CKAP2 as a diagnostic biomarker for bladder cancer. World J Surg Oncol Li X, Yang J, Cha J, Xie H, Dong C, Yang Y, Li Y, Guo J, Lin C. PMID: 42337544 [PubMed - as supplied by publisher]
	Pro-neuropeptide Y as a circulating biomarker for poor prognosis in prostate cancer. Sci Rep Djusberg E, Lundquist K, Lundholm M, Josefsson A, Karlsson CT, Schwenk JM, Brattsand M, Bergh A, Wikström P. PMID: 42337319 [PubMed - indexed for MEDLINE]
	Multifactorial diagnostic model combining SAT-PCA3 in prostate cancer. Discov Oncol Luo Z, Dai S, Jin J, Xie W, Lei S, He Y. PMID: 42337216 [PubMed - as supplied by publisher]
	Front-line chemo-immunotherapy for advanced penile cancer: ready for prime time? Br J Cancer Thomas Z, Pettaway CA, Alhalabi O, Campbell MT, Johns AC. PMID: 42337045 [PubMed - as supplied by publisher]
	How will PLUDO, PSMAfore, SPLASH, and ECLIPSE Impact Prostate Cancer Management? Eur Urol Focus Beauregard JM, Ong M, Pouliot F. PMID: 42336749 [PubMed - as supplied by publisher]

Articles 1 - 20 / 179205

Page 1 of 8961



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy